Autoimmune manifestations in the transforming growth factor-β1 knockout mouse

Blood

Volumn 87, Issue 4, 1996, Pages 1439-1445

  Yaswen, Linda ^b   Kulkarni, Ashok B ^b   Fredrickson, Torgny ^b   Mittleman, Barbara ^b   Schiffmann, Raphael ^b   Payne, Susan ^b   Longenecker, Glenn ^b   Mozes, Edna ^b   Karlsson, Stefan ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BASEMENT MEMBRANE ANTIBODY; DNA ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; ETIOLOGY; GAMMA IRRADIATION; GENE DISRUPTION; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030063832     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1439.bloodjournal8741439     Document Type: Article

References (34)

1. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597, 1990
2. McCartney-Francis NL, Wahl SM: Transforming growth factor β: A matter of life and death. J Leukoc Biol 55:401, 1994
3. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1, 1993
4. Kulkarni AB, Huh C, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn M, Ward JM, Karlsson S: Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770, 1993
5. Shull MM Ormsby IE, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693, 1992
6. Kulkarni AB, Karlsson S: Transforming growth factor-β1 knockout mice: A mutation in one cytokine causes a dramatic inflammatory disease. Am J Pathol 143:3, 1993
7. Kulkarni AB, Ward JM, Yaswen LR, Mackall CL, Bauer SR, Huh CG, Gress RE, Karlsson S: Transforming growth factor-β1 null mice: An animal model for inflammatory disorders. Am J Pathol 146:1, 1995
8. Hines KL, Kulkarni AB, McCarthy JB, Tian H, Ward JM, Christ M, McCartney-Francis NL, Furcht LT, Karlsson S, Wahl SM: Synthetic fibronectin peptides interrupt inflammatory cell infiltration in TGFβ1 knockout mice. Proc Natl Acad Sci USA 91:5187, 1994
9. Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB: TGF-β1 controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc Natl Acad Sci USA 90:9944, 1993
10. Wahl SM: Transforming growth factor-β (TGF-β) in inflammation: A cause and a cure. J Clin Immunol 12:61, 1992
11. Santambrogio L, Hochwald GM, Saxena B, Leu CH, Martz JE, Carlino JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ: Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J Immunol 151:1116, 1993
12. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine C, McFarlin DE: Prevention and treatment of chronic relapsing allergic encephalomyelitis by transforming growth factor β1. J Immunol 146:3012, 1991
13. Brandes ME, Allen JB. Ogawa Y, Wahl SM: Transforming growth factor β1 suppresses acute and chronic arthritis in experimen-tal animals. J Clin Invest 87:1108, 1991
14. Johns LD, Flanders KC, Ranges GE, Sriram S: Successful treatment of experimental allergic encephalomyelitis with transforming growth factor β1. J Immunol 147:1792, 1991
15. Kuruvilla AP, Shah R, Hochwald GM, Ligitt HD, Palladino M, Thorbecke GJ: Protective effect of transforming growth factor-β1 on experimental autoimmune diseases in mice. Proc Nad Acad Sci USA 88:2918, 1991
16. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sei USA 89:421, 1992
17. Khoury SI, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176:1355, 1992
18. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
19. Mendlovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E: Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci USA 85:2260, 1988
20. Correll PH, Colilla S, Dave HPG, Karlsson S: High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoitic stem cells. Blood 80:331, 1992
21. Schiffmann R, Medin J, Ward J, Stahl S, Cottler-Fox M, Karlsson S: Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: Successful engraftment and long-term expression of the transgene. Blood 86:1218, 1995
22. Green MC, Witham BA (ed): Handbook on Genetically Standardized Jax Mice. Bar Harbor, ME, The Jackson Laboratory, 1991
23. Klein J, Figueroa F, David CS: H-2 haplotypes, genes and antigens: Second listing. Immunogenetics 17:553, 1983
24. Schwartz RS, Datta SK: Autoimmunity and autoimmune diseases, in Paul WE (ed): Fundamental Immunology. New York, NY, Raven, 1989, p 819
25. Isenberg DA, Collins C: Detection of cross reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from SLE-patients. J Clin Invest 76:287, 1985
26. Isenberg DA, Shoenfeld Y, Madaio MP, Rauch J, Reichlin M, Stollar BD Schwartz RS: Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 2:417, 1984
27. Letterio J, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB: Maternal rescue of transforming growth factor-β1 null mice. Science 264:1936, 1994
28. Boivin GP, O'Toole BA, Orsmby IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB: Onset and progression of pathological lesions in transforming growth factor-β1 -deficient mice. Am J Pathol 146:276, 1995
29. Espevik T, Figari IS, Shalaby MR, Lakides GA, Lewis GD, Shepard HM, Palladino MA: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571, 1987
30. Wallik SC, Figari IS, Morris RE, Levinson AD, Palladino MA: Immunoregulatory role of transforming growth factor β (TGFβ) in development of killer cells: Comparison of active and latent TGF-β1. J Exp Med 172:1777, 1990
31. Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, Mackall CL, Gress RE, Hines KL, Tian H, Karlsson S, Wahl SM: Immune dysregulation in TGF-β1-deficient mice. J Immunol 153:1936, 1994
32. Lowrance JH, O'Sullivan FX, Caver TE, Waegell W, Gresham HD: Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J Exp Med 180:1693, 1994
33. Talal N, Dang H, Geiser A, Letterio J, Sporn M: Generalized autoimmunity and lymphoproliferation in TGF-β1 knockout mice. Clin Res 42:304a, 1994
34. Yaswen L, Kulkarni AB, Ward J, Schiffmann R, Mozes E, Karlsson S: Potential autoimmune etiology in TGF-β1 knockout mouse immune dysregulation. Blood 84:496a, 1994 (abstr, suppl 1)